Details for New Drug Application (NDA): 206381
✉ Email this page to a colleague
The generic ingredient in ROSUVASTATIN CALCIUM is rosuvastatin calcium. There are forty-two drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the rosuvastatin calcium profile page.
Summary for 206381
Tradename: | ROSUVASTATIN CALCIUM |
Applicant: | Sciegen Pharms Inc |
Ingredient: | rosuvastatin calcium |
Patents: | 0 |
Pharmacology for NDA: 206381
Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for 206381
Suppliers and Packaging for NDA: 206381
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 206381 | ANDA | A-S Medication Solutions | 50090-7240 | 50090-7240-0 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-7240-0) |
ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 206381 | ANDA | A-S Medication Solutions | 50090-7240 | 50090-7240-1 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-7240-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Apr 24, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Apr 24, 2019 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Apr 24, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription